Mobile App Training for Impulsivity
(DelTA Trial)
Trial Summary
What is the purpose of this trial?
Deficits in self-control are of major public health relevance as they contribute to several negative outcomes for both individuals and society. For children, developing self-control is a critically important step toward success in academic settings and social relationships, yet there are few non-pharmacological approaches that have been successful in increasing self-control. We found in our earlier studies that self-control can be increased in preschool-aged children with high impulsivity by using games in which they practice gradually increasing wait-time for larger, more delayed rewards. We are performing this current study to test if this training to increase self-control can be increased using mobile app technology, with computerized game time being used as a reward.
Will I have to stop taking my current medications?
Participants can continue taking their current medications, but they must keep the same medication and dose throughout the study.
What data supports the effectiveness of the treatment Shaping Delay Tolerance, Delay Tolerance Training, Self-Control Enhancement for impulsivity?
Research shows that impulsivity, a key issue in conditions like ADHD and addiction, can be linked to difficulties in delaying gratification and waiting for rewards. Studies suggest that improving self-control and delay tolerance may help manage impulsivity by enhancing the ability to wait for future rewards.12345
Is the mobile app training for impulsivity safe for humans?
How is the Shaping Delay Tolerance treatment different from other treatments for impulsivity?
Research Team
Julie B Schweitzer, PhD
Principal Investigator
UC Davis MIND Institute
Eligibility Criteria
This trial is for preschool-aged children (3-6 years old) who show high levels of impulsivity, as indicated by specific rating scales. They must be physically and visually able to use a tablet and if on medication, keep the same type throughout the study.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-treatment
Participants in the Wait-list Control arm undergo effortful control assessments and behavior questionnaires
Treatment
Participants receive the Shaping Delay Tolerance behavioral intervention
Follow-up
Participants are monitored for changes in self-control and impulsivity through various tasks and questionnaires
Treatment Details
Interventions
- Shaping Delay Tolerance (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor
Rakesh Dixit
University of California, Davis
Chief Executive Officer since 2024
PhD in Biochemistry and Molecular Biology from the University of California, Davis
Suresh Mahabhashyam
University of California, Davis
Chief Medical Officer since 2020
MD from Bangalore Medical College
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Dr. Diana W. Bianchi
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Executive Officer since 2016
MD from Stanford University
Dr. Alison Cernich
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Medical Officer since 2020
PhD in Clinical Psychology from University of Maryland